Logo image
Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy
Journal article   Open access   Peer reviewed

Characterization of δ-Sarcoglycan, a Novel Component of the Oligomeric Sarcoglycan Complex Involved in Limb-Girdle Muscular Dystrophy

Daniel Jung, Franck Duclos, Barbara Apostol, Volker Straub, Jane C Lee, Valérie Allamand, David P Venzke, Yoshihide Sunada, Carolyn R Moomaw, Cynthia J Leveille, …
The Journal of biological chemistry, Vol.271(50), pp.32321-32329
12/13/1996
DOI: 10.1074/jbc.271.50.32321
PMID: 8943294
url
https://doi.org/10.1074/jbc.271.50.32321View
Published (Version of record) Open Access

Abstract

The sarcoglycan complex is known to be involved in limb-girdle muscular dystrophy (LGMD) and is composed of at least three proteins: α-, β-, and γ-sarcoglycan. δ-Sarcoglycan has now been identified as a second 35-kDa sarcolemmal transmembrane glycoprotein that shares high homology with γ-sarcoglycan and is expressed mainly in skeletal and cardiac muscle. Biochemical analysis has demonstrated that γ- and δ-sarcoglycan are separate entities within the sarcoglycan complex and that all four sarcoglycans exist in the complex on a stoichiometrically equal basis. Immunohistochemical analysis of skeletal muscle biopsies from patients with LGMD2C, LGMD2D, and LGMD2E demonstrated a reduction of the entire sarcoglycan complex in these muscular dystrophies. Furthermore, we have mapped the human δ-sarcoglycan gene to chromosome 5q33-q34 in a region overlapping the recently linked autosomal recessive LGMD2F locus.

Details

Metrics

Logo image